[1]Mok C C, Birmingham D, Ho L Y, et al. High sensitivity C-Reactive protein, disease activity and cardiovascular risk factors in systemic lupus erythematosus[J]. Arthritis Rheum, 2012,64(10, S):S953 [2]Bombardier C, Gladman D D, Urowitz M B, et al. The committee on prognosis studies in SLE:derivation of the SLEDAI:a disease activity index for lupus patients[J]. Arthritis Rheum, 1992,35(6):630 [3]Ward M M, Guthrie L C, Alba M I. Clinically important changes in individual and composite measures of rheumatoid arthritis activity:thresholds applicable in clinical trials[J]. Ann Rheum Dis, 2014,73(5):1 [4]Villa I, Agudo B M, Martínez-Taboada V M. Advances in the diagnosis of large vessel vasculitis:identification of biomarkers and imaging studies[J]. Reumatol Clin, 2011,7(S3):S22 [5]张晓慧,李光韬,张卓莉. C反应蛋白与超敏C反应蛋白的检测及其临床意义[J]. 中华临床免疫和变态反应杂志, 2011,5(1):74 [6]周明莉,蔡爱玲,王雪峰. 降钙素原及C反应蛋白测定在新生儿感染性疾病诊断中的应用[J]. 国际检验医学杂志, 2011,32(6):683 [7]Wadhwa A, Avasthi R, Ghambhir J K, et al. To study the prevalence and profile of metabolic syndrome,levels of hs-CRP,Lp(a)and serum ferritin in young Indian patients(<or=45 years)with acute myocardial infarction[J]. J Assoc Physicians India, 2013,61(6):384 [8]Szalai A J. C-reactive protein(CRP)and autoimmune disease:facts and conjectures[J]. Clin Dev Immunol, 2004,11(324):221 [9] Rekvig OP, Van der Vlag J.The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved[J].Semin Immunopathol,2014,36(3):301 [10]Lee S S, Singh S, Magder L S, et al. Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus[J]. Lupus, 2008,17(2):114
[1]陈 宪,周 蕾,庞 杰,等.血尿酸与系统性红斑狼疮患者肾损害的关系[J].天津医科大学学报,2014,20(01):42.
CHEN Xian,ZHOU Lei,PANG Jie,et al.Association of serum uric acid with lupus nephritis in systemic lupus erythematosus patients[J].Journal of Tianjin Medical University,2014,20(03):42.
[2]李晓洁,周 蕾,陈 宪,等.超敏C反应蛋白和补体C3与系统性红斑狼疮疾病活动度的关系[J].天津医科大学学报,2015,21(01):63.
LI Xiao-jie,ZHOU Lei,CHEN Xian,et al.Relationship between high-sensitivity C-reactive protein, complement 3 andwith disease activity in systemic lupus erythematosus[J].Journal of Tianjin Medical University,2015,21(03):63.
[3]徐 萍,周 蕾.血清β2-微球蛋白与系统性红斑狼疮疾病活动度及其肾脏损害的相关性[J].天津医科大学学报,2017,23(01):41.
XU Ping,ZHOU Lei.Relationship between serum levels of β2-microspheres and disease activity together with renal damage in systemic lupus erythematosus patients[J].Journal of Tianjin Medical University,2017,23(03):41.
[4]赵 冕,朱桂晋,周 蕾.系统性红斑狼疮患者血清IL-17和IL-35水平及其与肾损害的关系[J].天津医科大学学报,2019,25(04):359.
ZHAO Mian,ZHU Gui-jin,ZHOU Lei.Serum IL-17 and IL-35 levels in patients with systemic lupus erythematosus and their correlations with renal damage[J].Journal of Tianjin Medical University,2019,25(03):359.
[5]朱桂晋,赵 冕,周 蕾.补体片段C5a与系统性红斑狼疮及其神经系统损害的关系[J].天津医科大学学报,2019,25(04):363.
ZHU Gui-jin,ZHAO Mian,ZHOU Lei.The effect of C5a on systemic lupus erythematosus and its damage of nervous system[J].Journal of Tianjin Medical University,2019,25(03):363.